Multiple Myeloma and Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Multiple Myeloma and Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial assessing donor stem cell transplant in patients with previously treated leukemia, lymphoma, or multiple myeloma; stu…
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant [NA]
Clinical trial update on donor lymphocyte infusion for patients with recurrent or persistent hematologic cancer after donor stem cell transp…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Phase 3]
Phase 3 trial comparing darbepoetin alfa with epoetin alfa for treating anemia in patients undergoing chemotherapy for cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial [Phase 3]
Phase 3 clinical trial update focusing on personalized or basic information to aid decision-making for participating in a trial.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Treatment for Chronic Pain in Patients With Advanced Cancer [Phase 3]
Phase 3 clinical trial update for a treatment addressing chronic pain in patients with advanced cancer; status indicates completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and Umbilical Cord Blood Transplantation for hematologic cancers complete…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial investigating mycophenolate mofetil, tacrolimus, daclizumab, and donor peripheral stem cell transplantation for hemat…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 4]
Phase 4 clinical trial update on bone marrow transplantation for hematologic cancers, including conditions such as anemia and graft-versus-h…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating total-body irradiation with fludarabine and peripheral stem cell transplantation in patients with hematologic cance…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer [Phase 2]
Phase 2 trial update on a combination chemotherapy, bone marrow transplant, and post-transplant cyclophosphamide regimen for hematologic can…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial assessing donor peripheral stem cell transplant with fludarabine and busulfan in hematologic cancers has completed; results po…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
This clinical trial update notes the termination of a study examining natural killer cells in bone marrow and blood from patients with and w…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation for patients undergoing donor b…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant [NA]
A completed clinical trial evaluated adding aprepitant to granisetron and dexamethasone to prevent nausea and vomiting in patients receiving…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [Phase 1]
This document provides a Phase 1 clinical trial update on using Interleukin-12 to treat various hematologic cancers and solid tumors; the st…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer [Phase 2]
This Phase 2 trial tested sirolimus, tacrolimus, and antithymocyte globulin for preventing graft-versus-host disease in patients undergoing …
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial evaluating sirolimus, tacrolimus, thymoglobulin, and rituximab as graft-versus-host-disease prophylaxis in haploidentical and …
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating a growth factor to prevent oral mucositis in patients with hematologic cancers. The study status is comple…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy [Phase 2]
Phase 2 trial update evaluating voriconazole to prevent fungal infections in children with neutropenia after chemotherapy. The study has com…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 clinical study evaluating sequential administration of Interleukin-12 followed by Interferon alfa in adults with advanced cancer; th…